TipRanks
Go Ultimate55% OFF

Fairmount Funds Management LLC Insider Profile

67 Followers

Fairmount Funds Management LLC, Director, Ten Percent Owner at Korsana Biosciences, holds ― shares in Korsana Biosciences (Ticker: KRSA), holds 0.00 shares in Apogee Therapeutics (Ticker: APGE), holds 3.60M shares in Crescent Biopharma (Ticker: CBIO).

Fairmount Funds Management LLC's Trading History

APGE
Apogee Therapeutics
Sep 03, 2026―Uninformative Sell―$0.00
CBIO
Crescent Biopharma
Jul 20, 2026Director, Ten Percent OwnerInformative Buy12.38M$49.77M
ORKA
Oruka Therapeutics
Jul 01, 2026Director, Ten Percent OwnerInformative Sell300.01M$375.75M
SYRE
Spyre Therapeutics
Jun 23, 2026DirectorInformative Sell399.66M$80.43M
VRDN
Viridian Therapeutics
May 13, 2026Director, Ten Percent OwnerInformative Buy20.00M$147.92M
ZBIO
Zenas BioPharma, Inc.
Apr 01, 2026DirectorInformative Buy3.00M$67.14M
COGT
Cogent Biosciences
Mar 31, 2026DirectorInformative Sell242.62M$173.30M
DMRA
Damora Therapeutics
Feb 12, 2026Director, Ten Percent OwnerUninformative Buy209.11M$199.88M
JBIO
Jade Biosciences
Oct 08, 2025Director, Ten Percent OwnerUninformative Buy12.18M$68.48M
DNTH
Dianthus Therapeutics
Oct 01, 2024DirectorUninformative Sell―$231.75M
KRSA
Korsana Biosciences
―Director, Ten Percent Owner――

You May Also Like

Fairmount Funds Management LLC insider profile FAQ

What is the percentage of profitable transactions made by Fairmount Funds Management LLC?
The percentage of profitable transactions made by Fairmount Funds Management LLC is 70%.
What is the average return per transaction made by Fairmount Funds Management LLC?
The average return per transaction made by Fairmount Funds Management LLC is 42.50%.
What stocks does Fairmount Funds Management LLC hold?
Fairmount Funds Management LLC holds: KRSA, ORKA, CBIO, VRDN, SYRE, COGT, DNTH, DMRA, JBIO, APGE, ZBIO stocks.
What was Fairmount Funds Management LLC's most profitable transaction?
Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of COGT stock on July 14, 2025. The return on the trade was 256.40%.
What is Fairmount Funds Management LLC's role in Korsana Biosciences?
Fairmount Funds Management LLC's role in Korsana Biosciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.